Ligands for peroxisome proliferator-activated receptor γ inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 5, 2001, Pages 2170-2177

  Ohta, Kazuyasu ^a   Endo, Toyoshi ^a   Haraguchi, Kazutaka ^a   Hershman, Jerome M ^b   Onaya, Toshimasa ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA12 PROSTAGLANDIN J2; LIGAND; MYC PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROTEIN BAX; PROTEIN BCL 2; ROSIGLITAZONE; TROGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, NORTHERN; CARCINOMA, PAPILLARY; CELL DIVISION; CHROMANS; HUMANS; MALE; MICE; MICE, INBRED BALB C; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; THYMIDINE; THYROID NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0035019640     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.5.2170     Document Type: Article

References (23)

1. Mazzaferri EL. 1996 Carcinoma of follicular epithelium. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid, ed 7. Philadelphia: Lippincott; 922-945.
2. Simpson WJ, Mckinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T. 1987 Papillary and follicular thyroid cancer-prognostic factors in 1578 patients. Am J Med. 83:479-488.
3. Mazzaferri EL, Robyn J. 1996 Postsurgical management of differentiated thyroid carcinoma. Otolaryngol Clin North Am. 29:637-663.
4. Samaan NA, Schltz PN, Hickey RC, et al. 1992 The results of various modalities of treatment of well-differentiated thyroid carcinoms: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 75:714-720.
5. McHenry CR, Rosen IB, Walfish PG. 1991 Prospective management of nodal metastasis in differentiated thyroid cancer. Am J Surg. 162:353-356.
6. Ohta K, Endo T, Onaya T. 1990 The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues. Biochem Biophys Res Commun. 165:1148-1153.
7. Fabbro D, DiLoreto C, Beltrami CA, DiLauro R, Damante G. 1994 Expression of thyroid specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res. 54:4744-4749.
8. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. 1994 Peroxisone proliferator-activated receptor (PPAR)γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology. 135:798-800.
9. Tontonoz P, Hu E, Spiegelman BM. 1994 Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell. 79:1147-1156.
10. Elstner E, Muller C, Koshizuka K, et al. 1998 Ligands for peroxisome proliferator-activated receptorγ and retinoid acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA. 95:8806-8811.
11. Kubota T, Koshizuka K, Williamson EA, et al. 1998 Ligand for peroxisome proliferator-activated receptor γ(Troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res. 58:3344-3352.
12. Tontonoz P, Singer S, Forman BM, et al. 1997 Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator- activated receptor γ and the retinoid X receptor. Proc Natl Acad Sci USA. 94:237-241.
13. Takahashi N, Okumura T, Motomura W, et al. 1999 Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett. 455:135-139.
14. Ohta K, Pang XP, Berg L, et al. 1996 Antitumor actions of cytokines on new human thyroid papillary carcinoma cell lines. J Clin Endocrinol Metab. 81:2607-2612.
15. Ohta K, Pang XP, Berg L, et al. 1997 Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the β-adrenergic receptor. J Clin Endocrinol Metab. 82:2633-2638.
16. Chomczynski P, Sacchi N. 1987 Single-step method of RNA by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-159.
17. Elbrecht A, Chen Y, Cullinan C, et al. 1996 Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ1 and γ2. Biochem Biophys Res Commun. 224:431-437.
18. Tokunaga K, Nakamura Y, Sakata K, et al. 1987 Enhanced expression of a glyceraldehyde-3-phoshate dehydrogenase gene in human lung cancers. Cancer Res. 47:5616-5619.
19. Tilly JL, Hsueh AJW. 1993 Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J Cell Physiol. 154:519-526.
20. Hale AJ, Smith CA, Sutherland LC, et al. 1996 Apoptosis: molecular regulation of cell death. Eur J Biochem. 236:1-26.
21. Brambilla E, Negoescu A, Gazzeri S, et al. 1996 Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol. 149:1941-1952.
22. Huffman B, Liebermann DA. 1998 The proto-oncogene c-myc and apoptosis. Oncogene. 17:3351-3357.
23. Evan IG, Wyllie AH, Gilbert CS, et al. 1992 Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:119-128.